 BERLIN, Sept. 03, 2021 GLOBE NEWSWIRE -- atai Life Sciences N.V. Nasdaq: ATAI atai, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in in the following upcoming investor conferences in September: 